Immune oncology (IO) and metastatic lung cancer [CBD]: Curability, bony metastasis and duration of therapy
The introduction of immune checkpoint inhibitors (ICI) instigated significant improvement in the management of metastatic NSCLC. Currently, metastatic NSCLC remains in the category of ‘incurable’ malignancies and there is no biologic or mechanistic basis to guide the duration of treatment with immun...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ca44d3c5070c4ceea8cf2379ae04ca66 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|